Blair Jackson
Förmögenhet: 11 M $ per 2026-08-31
Förmögenhet: 11 M $ per 2026-08-31
Mr. Blair C.
Jackson is a President, Chief Executive Officer & Director at Alkermes Plc, a President, Chief Executive Officer & Director at Alkermes, Inc. and a Chairman & President at Rodin Therapeutics, Inc. He is on the Board of Directors at Synchronicity Pharma, Inc., Alkermes Plc, Alkermes, Inc. and Alkermes Pharma Ireland Ltd. Mr. Jackson also served on the board at Civitas Therapeutics, Inc. He received his undergraduate degree from the University of Alberta, an undergraduate degree from the University of Calgary, a graduate degree from Massachusetts Institute of Technology and an MBA from the University of Alberta.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-05 | 241 308 ( 0,14 % ) | 11 M $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| ALKERMES PLC | Verkställande Direktör | 2026-08-01 |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Verkställande Direktör | 2026-08-01 |
Alkermes Pharma Ireland Ltd.
Alkermes Pharma Ireland Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures oral dosage products | Direktör/Styrelseledamot | - |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Discovers, develops and commercializes novel therapeutics | Direktör/Styrelseledamot | 2018-10-01 |
Rodin Therapeutics, Inc.
Rodin Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disorders | Ordförande | - |
| Företag | Position | Slut |
|---|---|---|
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Direktör/Styrelseledamot | 2015-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Alberta
University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Calgary
University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Discovers, develops and commercializes novel therapeutics | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Alkermes Plc
Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Alkermes Pharma Ireland Ltd.
Alkermes Pharma Ireland Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures oral dosage products | Health Technology |
Rodin Therapeutics, Inc.
Rodin Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån